The role of plasminogen activators in the development of atherosclerotic and restenotic lesions

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 33-35

  Lupu, F ^a   Gerard, D ^a   Esmail, A ^a   Moradoghli Haftvani, A ^a   Kakkar, V V ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ATHEROSCLEROSIS; CONFERENCE PAPER; HUMAN; MACROPHAGE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STENOSIS;

EID: 0029855191     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80043-9     Document Type: Conference Paper

References (19)

1. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
2. Simionescu, N., R. Mora, E. Vasile, F. Lupu, D. A. Filip, and M. Simionescu. Prelesional modifications of the vessel wall in hyperlipidemic atherogenesis. Extracellular accumulation of modified and reassembled lipoproteins. Ann. N. Y. Acad. Sci. 1990; 598:1-16.
3. Sato, Y. and D. B. Rifkin. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J. Cell Biol. 1989; 109:309-315.
4. Saksela, O. and D. B. Rifkin. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 1990; 110:767-775.
5. Bachmann, F. Fibrinolysis. In: Verstraete M, Vermylen J, Lijnen R, Arnout J, eds. Thrombosis and Haemostasis. Leuven: Leuven University Press, 1987: 227-265.
6. Hamsten, A., G. Walldius, A. Szamosi, M. Blomback, U. De Faire, G. Dahlen, C. Landou, and B. Wiman. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2:3-9.
7. Schneiderman, J., M. S. Sawdey, M. R. Keeton, G. M. Bordin, E. F. Bernstein, R. B. Dilley, and D. J. Loskutoff. Increased type 1 plasminogen activator gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 1992; 89:6998-7002.
8. Lupu, F., G. E. Bergonzelli, D. A. Heim, E. Cousin, C. Y. Genton, F. Bachmann, and E. K. O. Kruithof. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler. Thromb. 1993; 13:1090-1100.
9. Bachmann, F., F. Lupu, D. Heim, G. Bergonzelli, and E. K. O. Kruithof. 1995. Fibrinolysis and atherosclerosis. In: V. Tilsner, F.R. Mathias eds. Hamburger Symposium über Blutgerinnung. Basel,/Grenzach-Wyhlen:Ed. Roche. 1995: 155-168.
10. Lupu, F., D. A. Heim, F. Bachmann, M. Hurni, V. V. Kakkar, and E. K. O. Kruithof. Plasminogen activator expression in human advanced atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 1995; 15:1444-1455.
11. Jackson, C. L., E. W. Raines, R. Ross, and M. A. Reidy. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler. Thromb. 1993; 13:1218-1226.
12. Ellis, V., N. Behrendt, and K. Danø. Cellular receptor for urokinase-type plasminogen activator: Function in cell-surface proteolysis. Methods Enzymol. 1993; 223:223-233.
13. Welgus, H. G., C. J. Fliszar, J. L. Seltzer, T. M. Schmid, and J. J. Jeffrey. Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase. J. Biol. Chem. 1990; 265:13521-13527.
14. Henney, A. M., P. R. Wakeley, M. J. Davies, K. Foster, R. Hembry, G. Murphy, and S. Humphries. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA 1991; 88:8154-8158.
15. Galis, G. S., G. K. Sukhova, M. W. Lark, and P. Libby. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 1994; 94:2493-2503.
16. 2-macroglobulin receptor in human normal and atherosclerotic arteries. Arterioscler. Thromb. 1994; 14:1438-1444.
17. Clowes, A. W., M. M. Clowes, Y. P. T. Au, M. A. Reidy, and D. Belin. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990; 67:61-67.
18. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368:419-424.
19. Carmeliet, P. and D. Collen. Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis. FASEB J. 1995; 9:934-938.